Nintedanib in idiopathic pulmonary fibrosis

被引：0
|
作者：
Venkatesan, Priya
机构：
来源：
LANCET RESPIRATORY MEDICINE | 2021年 / 9卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
下载
收藏
页码：E108 / E108
页数：1
相关论文
共 50 条
  • [41] Nintedanib and Pirfenidone as a Bridge to Lung Transplant in Idiopathic Pulmonary Fibrosis
    Li, D.
    Mason, W.
    Hoy, H.
    Robbins, I.
    Loyd, J.
    Lancaster, L.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [42] BUDGET IMPACT ANALYSIS OF NINTEDANIB IN IDIOPATHIC PULMONARY FIBROSIS IN TURKEY
    Demir, O.
    Tetik, E.
    Cheynel, J.
    Yildiz, L.
    VALUE IN HEALTH, 2018, 21 : S444 - S445
  • [43] Nintedanib: A Review of Its Use in Patients with Idiopathic Pulmonary Fibrosis
    Gillian M. Keating
    Drugs, 2015, 75 : 1131 - 1140
  • [44] Safety, tolerability and appropriate use of nintedanib in idiopathic pulmonary fibrosis
    Tamera Corte
    Francesco Bonella
    Bruno Crestani
    Maurits G. Demedts
    Luca Richeldi
    Carl Coeck
    Katy Pelling
    Manuel Quaresma
    Joseph A. Lasky
    Respiratory Research, 16
  • [45] Acute exacerbations in the INPULSIS trials of nintedanib in idiopathic pulmonary fibrosis
    Collard, Harold R.
    Richeldi, Luca
    Kim, Dong Soon
    Taniguchi, Hiroyuki
    Tschoepe, Inga
    Luisetti, Maurizio
    Roman, Jesse
    Tino, Gregory
    Schlenker-Herceg, Rozsa
    Hallmann, Christoph
    du Bois, Roland M.
    EUROPEAN RESPIRATORY JOURNAL, 2017, 49 (05)
  • [46] Efficacy and safety of nintedanib in patients with advanced idiopathic pulmonary fibrosis
    Luca Richeldi
    Martin Kolb
    Stéphane Jouneau
    Wim A. Wuyts
    Birgit Schinzel
    Susanne Stowasser
    Manuel Quaresma
    Ganesh Raghu
    BMC Pulmonary Medicine, 20
  • [47] Nintedanib: A Review of Its Use in Patients with Idiopathic Pulmonary Fibrosis
    Keating, Gillian M.
    DRUGS, 2015, 75 (10) : 1131 - 1140
  • [48] Tolerability and safety of nintedanib in elderly patients with idiopathic pulmonary fibrosis
    Uchida, Yoshinori
    Ikeda, Satoshi
    Sekine, Akimasa
    Katano, Takuma
    Tabata, Erina
    Oda, Tsuneyuki
    Okuda, Ryo
    Kitamura, Hideya
    Baba, Tomohisa
    Komatsu, Shigeru
    Ogura, Takashi
    RESPIRATORY INVESTIGATION, 2021, 59 (01) : 99 - 105
  • [49] Nintedanib: evidence for its therapeutic potential in idiopathic pulmonary fibrosis
    Inomata, Minoru
    Nishioka, Yasuhiko
    Azuma, Arata
    CORE EVIDENCE, 2015, 10 : 89 - 98
  • [50] Nintedanib in Severe Idiopathic Pulmonary Fibrosis: Effectiveness through Compassion
    Tzouvelekis, Argyrios
    Bouros, Demosthenes
    RESPIRATION, 2018, 95 (06) : 401 - 402
12345